Cargando…

Clinically relevant effect of rupatadine 20 mg and 10 mg in seasonal allergic rhinitis: a pooled responder analysis

BACKGROUND: Different clinical trials showed the superior efficacy of rupatadine compared to placebo at improving seasonal allergic rhinitis (SAR) symptoms, but no study has assessed if the response promoted is clinically meaningful. METHODS: This study is a pooled analysis of data of seven randomiz...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mullol, Joaquim, Izquierdo, Iñaki, Okubo, Kimihiro, Canonica, Giorgio Walter, Bousquet, Jean, Valero, Antonio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6784348/ https://www.ncbi.nlm.nih.gov/pubmed/31624533 http://dx.doi.org/10.1186/s13601-019-0293-4

Ejemplares similares

Higher efficacy of rupatadine 20 mg and 10 mg versus placebo in patients with perennial allergic rhinitis: a pooled responder analysis
por: Valero, Antonio, et al.
Publicado: (2020)

Morning and evening efficacy evaluation of rupatadine (10 and 20 mg), compared with cetirizine 10 mg in perennial allergic rhinitis: a randomized, double-blind, placebo-controlled trial
por: Marmouz, Farid, et al.
Publicado: (2011)

Long-term safety and efficacy of rupatadine in Japanese patients with perennial allergic rhinitis: a 52-week open-label clinical trial
por: Okubo, Kimihiro, et al.
Publicado: (2019)

Evaluation of nasal symptoms induced by platelet activating factor, after nasal challenge in both healthy and allergic rhinitis subjects pretreated with rupatadine, levocetirizine or placebo in a cross-over study design
por: Muñoz-Cano, Rosa, et al.
Publicado: (2013)

Rupatadine Oral Solution Titration by Body Weight in Paediatric Patients Suffering from Allergic Rhinitis: A Population Pharmacokinetic Study
por: Santamaria, Eva, et al.
Publicado: (2021)

Olopatadine hydrochloride and rupatadine fumarate in seasonal allergic rhinitis: A comparative study of efficacy and safety
por: Maiti, Rituparna, et al.
Publicado: (2011)

Rupatadine oral solution for 2–5-year-old children with allergic rhinitis: a safety, open-label, prospective study
por: Santamaría, Eva, et al.
Publicado: (2018)

Morning and evening efficacy evaluation of rupatadine (10 and 20 mg), compared with cetirizine 10 mg in perennial allergic rhinitis: a randomized, double-blind, placebo-controlled trial [Corrigendum]
Publicado: (2015)

Management of persistent allergic rhinitis: evidence-based treatment with levocetirizine
por: Mullol, Joaquim, et al.
Publicado: (2005)

Pharmacokinetics, Safety and Cognitive Function Profile of Rupatadine 10, 20 and 40 mg in Healthy Japanese Subjects: A Randomised Placebo-Controlled Trial
por: Täubel, Jörg, et al.
Publicado: (2016)

Efficacy and Safety of Rupatadine Fumarate Combined with Acupoint Application in Allergic Rhinitis Complicated with Diabetes
por: Liu, Yu, et al.
Publicado: (2022)

FUTURA STUDY-Evaluation of efficacy and safety of rupatadine fumarate in the treatment of persistent allergic rhinitis
por: de Godoy Mion, Olavo, et al.
Publicado: (2015)

Rupatadine oral solution improves rhino-conjunctive symptoms control in children with 6-11 years weighing ≥25 kg with persistent allergic rhinitis
por: Izquierdo, Iñaki, et al.
Publicado: (2013)

The hidden burden of adult allergic rhinitis: UK healthcare resource utilisation survey
por: Price, David, et al.
Publicado: (2015)

Patient Perceptions of Allergic Rhinitis and Quality of Life: Findings From a Survey Conducted in Europe and the United States
por: Canonica, G Walter, et al.
Publicado: (2008)

Causal Relationships Among Pollen Counts, Tweet Numbers, and Patient Numbers for Seasonal Allergic Rhinitis Surveillance: Retrospective Analysis
por: Wakamiya, Shoko, et al.
Publicado: (2019)

Platelet-Activating Factor (PAF) in Allergic Rhinitis: Clinical and Therapeutic Implications
por: Muñoz-Cano, Rosa M., et al.
Publicado: (2019)

Measuring outcomes in allergic rhinitis: psychometric characteristics of a Spanish version of the congestion quantifier seven-item test (CQ7)
por: Valero, Antonio, et al.
Publicado: (2011)

Rupatadine
por: Kaur, Manpreet, et al.
Publicado: (2013)

A common language to assess allergic rhinitis control: results from a survey conducted during EAACI 2013 Congress
por: Hellings, Peter W., et al.
Publicado: (2015)

A direct comparison of efficacy between desloratadine and rupatadine in seasonal allergic rhinoconjunctivitis: a randomized, double-blind, placebo-controlled study
por: Lukat, KF, et al.
Publicado: (2013)

Current treatment strategies for seasonal allergic rhinitis: where are we heading?
por: Ridolo, Erminia, et al.
Publicado: (2022)

Antihistamines for Allergic Rhinitis Treatment from the Viewpoint of Nonsedative Properties
por: Kawauchi, Hideyuki, et al.
Publicado: (2019)

Management of allergic rhinitis symptoms in the pharmacy Pocket guide 2022
por: Lourenço, Olga, et al.
Publicado: (2022)

Comparison of efficacy, safety, and cost-effectiveness of rupatadine and olopatadine in patients of allergic rhinitis: A prospective, randomized, double-blind, parallel group study
por: Dakhale, Ganesh, et al.
Publicado: (2016)

Allergic rhinitis and asthma symptoms in a real-life study of MP-AzeFlu to treat multimorbid allergic rhinitis and asthma
por: Price, David, et al.
Publicado: (2020)

Physicians’ prescribing behaviour and clinical practice patterns for allergic rhinitis management in Italy
por: Passalacqua, Giovanni, et al.
Publicado: (2020)

Platelet activating factor-induced mast cell degranulation is inhibited by rupatadine, and to a lower extent by levocetirizine and desoratadine, in a mast cell line (LAD-2)
por: Mullol, Joaquim, et al.
Publicado: (2013)

Local Nasal Specific Immunotherapy for Allergic Rhinitis
por: Passalacqua, Giovanni, et al.
Publicado: (2006)

Persistent Allergic Rhinitis and the XPERT Study
por: Rogkakou, Anthi, et al.
Publicado: (2011)

Corrigendum: Treatment of allergic rhinitis during and outside the pollen season using mobile technology. A MASK study
por: Jean, Bousquet
Publicado: (2022)

Escaping the trap of allergic rhinitis
por: Rossi, Oliviero, et al.
Publicado: (2015)

Population pharmacokinetic modelling of rupatadine solution in 6–11 year olds and optimisation of the experimental design in younger children
por: Santamaría, Eva, et al.
Publicado: (2017)

Chronic rhinosinusitis with nasal polyps and allergic rhinitis as different multimorbid treatable traits in asthma
por: Castillo, José Antonio, et al.
Publicado: (2023)

New guidelines for the treatment of seasonal allergic rhinitis
por: Emeryk, Andrzej, et al.
Publicado: (2019)

Rupatadine to prevent local allergic reactions to sublingual allergy immunotherapy: a case series
por: Ellis, Anne K., et al.
Publicado: (2021)

Cystatin SN Upregulation in Patients with Seasonal Allergic Rhinitis
por: Imoto, Yoshimasa, et al.
Publicado: (2013)

Seasonal Allergic Rhinitis Symptoms in Relation to COVID-19
por: Bruno, Chiara, et al.
Publicado: (2020)

Omalizumab is effective in the preseasonal treatment of seasonal allergic rhinitis
por: Zhang, Yuan, et al.
Publicado: (2022)

MP-AzeFlu Improves the Quality-of-Life of Patients with Allergic Rhinitis
por: van Weissenbruch, Ranny, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_r6c2j19v1shi5th6044i7jf7vq